• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combination immune checkpoint inhibition for older patients with oesophageal squamous cell cancer.

作者信息

Baker Harriet C, Smyth Elizabeth C

机构信息

Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK.

出版信息

Lancet Healthy Longev. 2022 Jun;3(6):e372-e373. doi: 10.1016/S2666-7568(22)00126-X. Epub 2022 Jun 9.

DOI:10.1016/S2666-7568(22)00126-X
PMID:36098313
Abstract
摘要

相似文献

1
Combination immune checkpoint inhibition for older patients with oesophageal squamous cell cancer.老年食管鳞状细胞癌患者的联合免疫检查点抑制治疗
Lancet Healthy Longev. 2022 Jun;3(6):e372-e373. doi: 10.1016/S2666-7568(22)00126-X. Epub 2022 Jun 9.
2
Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma.免疫检查点抑制剂在晚期食管鳞状细胞癌患者中的疗效证据
JAMA Oncol. 2023 Jul 1;9(7):1004-1005. doi: 10.1001/jamaoncol.2023.0972.
3
Evidence on Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma-Reply.
JAMA Oncol. 2023 Jul 1;9(7):1005-1006. doi: 10.1001/jamaoncol.2023.0975.
4
Prolonging Survival in Advanced Esophageal Squamous Cell Carcinoma With Immune Checkpoint Inhibitors.免疫检查点抑制剂延长晚期食管鳞状细胞癌患者生存期
Gastroenterology. 2022 Aug;163(2):527. doi: 10.1053/j.gastro.2022.05.042. Epub 2022 Jun 2.
5
Nivolumab induced hyperprogressive disease in advanced esophageal squamous cell carcinoma.纳武单抗在晚期食管鳞状细胞癌中诱发了超进展性疾病。
Cancer Biol Ther. 2020 Dec 1;21(12):1097-1104. doi: 10.1080/15384047.2020.1834319. Epub 2020 Nov 5.
6
Combination chemo-immunotherapy in advanced oesophageal squamous cell carcinoma.晚期食管鳞状细胞癌的联合化疗免疫疗法
Lancet Oncol. 2023 May;24(5):419-420. doi: 10.1016/S1470-2045(23)00151-1. Epub 2023 Apr 17.
7
Current perspectives of the Japanese Esophageal Oncology Group on the development of immunotherapy for esophageal cancer.日本食管癌肿瘤学组对食管癌免疫治疗发展的现状观点。
Jpn J Clin Oncol. 2022 Oct 6;52(10):1089-1096. doi: 10.1093/jjco/hyac138.
8
Comment on "Toxic epidermal necrolysis during camrelizumab treatment for oesophageal squamous cell carcinoma".关于“卡瑞利珠单抗治疗食管鳞状细胞癌期间发生中毒性表皮坏死松解症”的评论
Contact Dermatitis. 2022 Oct;87(4):387-388. doi: 10.1111/cod.14179. Epub 2022 Jul 10.
9
JUPITER-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma.JUPITER-06研究确立了免疫检查点抑制剂作为晚期食管鳞状细胞癌一线治疗的基础用药地位。
Cancer Cell. 2022 Mar 14;40(3):238-240. doi: 10.1016/j.ccell.2022.02.009. Epub 2022 Mar 3.
10
Prognostic and predictive impact of neutrophil-to-lymphocyte ratio and HLA-I genotyping in advanced esophageal squamous cell carcinoma patients receiving immune checkpoint inhibitor monotherapy.中性粒细胞与淋巴细胞比值和 HLA-I 基因分型对接受免疫检查点抑制剂单药治疗的晚期食管鳞状细胞癌患者的预后和预测影响。
Thorac Cancer. 2022 Jun;13(11):1631-1641. doi: 10.1111/1759-7714.14431. Epub 2022 Apr 18.